Vault-13

CASI PHARMACEUTICALS INC CASIF

ORD SHS · Common Stock · CUSIP G1933S101

1 institutional holders -15 vs Q4 2025
228228 shares reported held*
0.0% of all shares outstanding*
$25reported value*
0 new 1 added 0 reduced 15 sold out net sold ≈ $137.3k (-1.3m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 20.6m as of 2025-12-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $0.11.

Trends to Q1 2026

Institutional holders

Managers reporting a position, each quarter

0102030Q4 22: 1Q1 23: 21Q2 23: 20Q3 23: 20Q4 23: 19Q1 24: 21Q2 24: 24Q3 24: 21Q4 24: 23Q1 25: 24Q2 25: 25Q3 25: 22Q4 25: 16Q1 26: 11Q4 22Q3 23Q2 24Q1 25Q1 26
Numbers
QuarterHolders
Q4 20221
Q1 202321
Q2 202320
Q3 202320
Q4 202319
Q1 202421
Q2 202424
Q3 202421
Q4 202423
Q1 202524
Q2 202525
Q3 202522
Q4 202516
Q1 20261

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
20020Q2 24: 9 bought or addedQ2 24: 9 cut or sold outQ3 24: 6 bought or addedQ3 24: 7 cut or sold outQ3 24Q4 24: 4 bought or addedQ4 24: 9 cut or sold outQ1 25: 8 bought or addedQ1 25: 4 cut or sold outQ1 25Q2 25: 7 bought or addedQ2 25: 10 cut or sold outQ3 25: 8 bought or addedQ3 25: 8 cut or sold outQ3 25Q4 25: 3 bought or addedQ4 25: 13 cut or sold outQ1 26: 1 bought or addedQ1 26: 15 cut or sold outQ1 26
Numbers
QuarterBought or addedCut or sold out
Q2 202499
Q3 202467
Q4 202449
Q1 202584
Q2 2025710
Q3 202588
Q4 2025313
Q1 2026115

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$500$1k$1.5k$2kQ2 25 calls: $0Q2 25 puts: $0Q2 25P/C —Q3 25 calls: $1.8kQ3 25 puts: $0Q3 25P/C 0.00Q4 25 calls: $935Q4 25 puts: $0Q4 25P/C 0.00Q1 26 calls: $0Q1 26 puts: $0Q1 26P/C —
Numbers
QuarterCallsPutsP/C
Q2 2025$0$0—
Q3 2025$1.8k$00.00
Q4 2025$935$00.00
Q1 2026$0$0—

Biggest buyers

SIMPLEX TRADING, LLC Added +95+95

Biggest sellers

Venrock Adviser, LLC Sold out -987,259-987.3k
Woodline Partners LP Sold out -133,406-133.4k
RENAISSANCE TECHNOLOGIES LLC Sold out -43,100-43.1k
TWO SIGMA INVESTMENTS, LP Sold out -23,787-23.8k
BANK OF AMERICA CORP /DE/ Sold out -19,935-19.9k
GEODE CAPITAL MANAGEMENT, LLC Sold out -18,808-18.8k
CITADEL ADVISORS LLC Sold out -14,045-14.0k
ROYAL BANK OF CANADA Sold out -9,950-9.9k
UBS Group AG Sold out -659-659
WELLS FARGO & COMPANY/MN Sold out -505-505

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
He Wei-Wu 13D · may seek influence +5.8 pts · filed 2026-05-18
Stated purposeOn April 17, 2026, ETP Global III Fund L.P. purchased a convertible note with the principal amount of US$5 million as the fourth tranche of the Issuer's US$20 million convertible note financing pursuant to certain convertible note purchase agreement (the "Purchase Agreement") between ETP Global III Fund L.P. and the Issuer dated December 11, 2025. A convertible note with a principal amount of US$5 million has been issued to the Purchaser on the same date (the "Convertible Note"). The Purchaser has the right to convert such note into the Company's ordinary shares, par value US$0.0001 per share (the "Ordinary Shares") at any time from and including the 91st day after the issuance thereof to and including the maturity date at a conversion price of the volume weighted average closing price of … Full filing
58.8% +5.8 pts 24.0m 2026-05-18
Panacea Innovation Ltd 13D · may seek influence +2.6 pts · filed 2025-12-17 22.5% +2.6 pts 4.7m 2025-12-17
Huang James 13G · passive investor filed 2025-07-23 13.8% 2.2m 2025-07-23
Chen Zhenfeng M 13G · passive new · filed 2025-11-26 11.0% new 2.3m 2025-11-26
Venrock Healthcare Capital Partners III, L.P. 13G · passive investor filed 2026-02-17 9.2% 2.0m 2026-02-17
SPARKLE BYTE LTD 13D · may seek influence filed 2026-01-20 5.0% 1.0m 2026-01-20

Fell to 5% or below in the last year: Foresite Capital Fund VI LP (0.0%, 2026-02-13), Ho Chi Sing (4.8%, 2026-01-20)

Insider purchases and sales in Q1 2026

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported in Q1 2026.

Holders, Q1 2026

#ManagerLocationShares Value% of their portfolioChangeShares change
1 SIMPLEX TRADING, LLC 0.00% of their portfolio CHICAGO, IL 228228 $25 $25 0.00% Added +95 +95